reported that m6A is enriched in the 3′-UTR of PD-L1 mRNA, corresponding to the immune checkpoint, and that the JNK signaling pathway promotes immune escape in bladder cancer by regulating m6A modifications of PD-L1 mRNA, mediated by METTL3 (153). This evidence concerns the gene CD274 and urinary bladder cancer.